LOXL2 and esophageal squamous cell carcinoma: LOXL2 was silenced in TE-1 cells and overexpressed in KYSE30 cells to verify the role and molecular mechanism of LOXL2 in ESCC cell progression, and as expected, silencing and overexpression of LOXL2 greatly affected cell proliferation, migration and invasion.